Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous angiosarcoma.

William M Mendenhall1, Charles M Mendenhall, John W Werning

  • 1Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA. mendewil@shands.ufl.edu

American Journal of Clinical Oncology
|October 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perineurioma-like EMA-positive calvarial neoplasms: clinicopathological study of eight cases.

Histopathology·2026
Same author

Perirectal spacers and endorectal balloons in external beam radiotherapy for prostate cancer: a review of prospective studies.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Same author

Robust Four-Field and Arc LET-Optimized Proton Prostate Cancer Treatment Plans With Urethral Sparing.

International journal of particle therapy·2026
Same author

Particle Therapy Co-Operative Group Consensus Statement on Reirradiation With Proton Therapy for Prostate Cancer.

International journal of particle therapy·2026
Same author

Ten-year outcomes for image-guided moderately hypofractionated proton therapy for prostate cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Does This Imaging Make Me Look NFATC2 ? The Value of Radiologic-pathologic Correlation in NFATC2 -rearranged Sarcomas of Bone.

The American journal of surgical pathology·2026
Same journal

Upper Extremity Lymphedema​​​: Performance of a Risk Prediction Model in Women Undergoing Surgery for Breast Cancer.

American journal of clinical oncology·2026
Same journal

Executive Summary of the American Radium Society (ARS) Appropriate Use Criteria (AUC) for the Use of Radiation in the Prevention and Treatment of Heterotopic Ossification (HO).

American journal of clinical oncology·2026
Same journal

Stereotactic Body Radiation Therapy Combined With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma: A Comprehensive Single-Arm Meta-Analysis Approach.

American journal of clinical oncology·2026
Same journal

Emergence of Single-Week Adjuvant Radiation Therapy for Early-Stage Breast Cancer in the United States.

American journal of clinical oncology·2026
Same journal

Early Versus Delayed Pancreatic Enzyme Replacement Therapy After Pancreatic Cancer Surgery: A Real-World Cohort Study.

American journal of clinical oncology·2026
Same journal

Early Economic and Patient-Centered Outcomes Before Spine Metastases Radiation Therapy From an Ongoing Phase II Randomized Controlled Trial.

American journal of clinical oncology·2026
See all related articles

Cutaneous angiosarcoma is a rare, aggressive cancer. Optimal treatment involves surgery and radiotherapy, but outcomes remain poor due to high recurrence and metastasis rates.

Area of Science:

  • Oncology
  • Dermatology
  • Surgical Oncology

Background:

  • Cutaneous angiosarcoma is a rare, aggressive vascular malignancy.
  • Typically affects the scalp and face, often presenting at an advanced stage.
  • Predominantly observed in elderly white males, with a subset exhibiting multifocal disease or nodal involvement.

Purpose of the Study:

  • To review the treatment strategies and patient outcomes for cutaneous angiosarcoma.
  • To highlight the challenges in managing this aggressive skin cancer.
  • To provide insights into prognostic factors and therapeutic efficacy.

Main Methods:

  • Comprehensive review of existing medical literature.
  • Analysis of treatment modalities and their associated outcomes.

Related Experiment Videos

  • Synthesis of data on prognosis, recurrence, and survival rates.

    • Main Results:

    • Optimal treatment combines surgical resection with wide-field radiotherapy (RT).
    • High rates of local-regional recurrence (40-50% 5-year control) and distant metastasis (60-80% 5-year metastasis-free survival).
    • Overall 5-year survival rates range from 10% to 30%; chemotherapy offers limited palliative benefit.

    Conclusions:

    • Cutaneous angiosarcoma necessitates aggressive management with surgery and postoperative RT.
    • Despite optimal treatment, significant risks of local-regional failure and distant relapse persist.
    • Chemotherapy may provide short-term palliation for advanced or metastatic disease.